{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:22:02Z","timestamp":1788348122824,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013465","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["23607"],"award-info":[{"award-number":["23607"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019470","name":"Lazio Innova spa","doi-asserted-by":"publisher","award":["A0375-2020- 36576"],"award-info":[{"award-number":["A0375-2020- 36576"]}],"id":[{"id":"10.13039\/100019470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005743","name":"Universita Cattolica del Sacro Cuore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2024.102427","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T19:27:08Z","timestamp":1734031628000},"page":"102427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome"],"prefix":"10.1016","volume":"36","author":[{"given":"Federica","family":"Tiberio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Tisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Massimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Tamburrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Arcovito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Falvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102427_bib1","series-title":"StatPearls","article-title":"Crouzon Syndrome","author":"Conrady","year":"2024"},{"key":"10.1016\/j.omtn.2024.102427_bib2","article-title":"Syndromic Craniosynostosis: A Comprehensive Review","volume":"15","author":"Katouni","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.omtn.2024.102427_bib3","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.3892\/mmr.2017.7397","article-title":"FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome","volume":"16","author":"Lin","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtn.2024.102427_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jobcr.2018.08.007","article-title":"Crouzon syndrome: Genetic and intervention review","volume":"9","author":"Al-Namnam","year":"2019","journal-title":"J.\u00a0Oral Biol. Craniofac. Res."},{"key":"10.1016\/j.omtn.2024.102427_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF03049602","article-title":"Crouzon syndrome: A case report and review of literature","volume":"58","author":"Kaur","year":"2006","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0994-98","article-title":"Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome","volume":"8","author":"Reardon","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3340\/jkns.2016.59.3.187","article-title":"Genetic Syndromes Associated with Craniosynostosis","volume":"59","author":"Ko","year":"2016","journal-title":"J.\u00a0Korean Neurosurg. Soc."},{"key":"10.1016\/j.omtn.2024.102427_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00006534-199802000-00007","article-title":"Mutation of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome","volume":"101","author":"Matsumoto","year":"1998","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.7150\/ijbs.22373","article-title":"Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis","volume":"13","author":"Azoury","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib10","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1038\/boneres.2014.3","article-title":"Role of FGF\/FGFR signaling in skeletal development and homeostasis: learning from mouse models","volume":"2","author":"Su","year":"2014","journal-title":"Bone Res."},{"key":"10.1016\/j.omtn.2024.102427_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ydbio.2016.03.026","article-title":"FGFR2c-mediated ERK-MAPK activity regulates coronal suture development","volume":"415","author":"Pfaff","year":"2016","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtn.2024.102427_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A Genetic-Pathophysiological Framework for Craniosynostosis","volume":"97","author":"Twigg","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib13","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.M109.055053","article-title":"FGF2-activated ERK Mitogen-activated Protein Kinase Enhances Runx2 Acetylation and Stabilization","volume":"285","author":"Park","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41586-023-06526-2","article-title":"A multi-stem cell basis for craniosynostosis and calvarial mineralization","volume":"621","author":"Bok","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102427_bib15","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.3390\/ijms21124356","article-title":"GLI1 and AXIN2 Are Distinctive Markers of Human Calvarial Mesenchymal Stromal Cells in Nonsyndromic Craniosynostosis","volume":"21","author":"Di Pietro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10006-014-0467-0","article-title":"Revisiting Crouzon syndrome: reviewing the background and management of a multifaceted disease","volume":"18","author":"Helman","year":"2014","journal-title":"Oral Maxillofac. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MOP.0000000000000542","article-title":"Clinical Genetics of Craniosynostosis","volume":"29","author":"Wilkie","year":"2017","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.omtn.2024.102427_bib18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/SCS.0000000000002016","article-title":"Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis","volume":"26","author":"Mathijssen","year":"2015","journal-title":"J.\u00a0Craniofac. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/SCS.0000000000009143","article-title":"Guideline on Treatment and Management of Craniosynostosis: Patient and Family Version","volume":"34","author":"Faasse","year":"2023","journal-title":"J.\u00a0Craniofac. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.optm.2006.03.005","article-title":"Crouzon syndrome","volume":"77","author":"Bowling","year":"2006","journal-title":"Optometry"},{"key":"10.1016\/j.omtn.2024.102427_bib21","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/ajmg.a.33703","article-title":"Genetic basis of potential therapeutic strategies for craniosynostosis","volume":"152","author":"Melville","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PRS.0000000000001058","article-title":"The importance of timing in optimizing cranial vault remodeling in syndromic craniosynostosis","volume":"135","author":"Utria","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/bjdm-2018-0001","article-title":"Crouzon syndrome: A comprehensive review","volume":"22","author":"Kyprianou","year":"2018","journal-title":"Balkan J. Dent. Med."},{"key":"10.1016\/j.omtn.2024.102427_bib24","first-page":"110","article-title":"Craniosynostosis - Recognition, clinical characteristics, and treatment","volume":"18","author":"Kajdic","year":"2018","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib25","article-title":"Severe chemosis and treatment following fronto-orbital advancement surgery for Crouzon syndrome","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.omtn.2024.102427_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0022034516643315","article-title":"Craniosynostosis and Resynostosis: Models, Imaging, and Dental Implications","volume":"95","author":"Hermann","year":"2016","journal-title":"J.\u00a0Dent. Res."},{"key":"10.1016\/j.omtn.2024.102427_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000493535","article-title":"Current Approaches in the Development of Molecular and Pharmacological Therapies in Craniosynostosis Utilizing Animal Models","volume":"10","author":"Rachwalski","year":"2019","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.omtn.2024.102427_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1247\/csf.25.85","article-title":"The pleiotropic effects of fibroblast growth factor receptors in mammalian development","volume":"25","author":"McIntosh","year":"2000","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.omtn.2024.102427_bib29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ng2096","article-title":"RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis","volume":"39","author":"Shukla","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.omtn.2018.09.012","article-title":"Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model","volume":"13","author":"Luo","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102427_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105753","article-title":"Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice","volume":"153","author":"Myo","year":"2023","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.omtn.2024.102427_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2024.102427_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.omtn.2024.102427_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00210-022-02245-z","article-title":"Nanotechnology in drug and gene delivery","volume":"395","author":"Hamimed","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102427_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.03.002","article-title":"Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer","volume":"107","author":"Truffi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2024.102427_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/app7010101","article-title":"Use of Ferritin-Based Metal-Encapsulated Nanocarriers as Anticancer Agents","volume":"7","author":"Mosca","year":"2017","journal-title":"Appl. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/mr-2023-0001","article-title":"Ferritin-based nanomedicine for disease treatment","volume":"3","author":"Zhu","year":"2023","journal-title":"Med. Rev."},{"key":"10.1016\/j.omtn.2024.102427_bib38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acs.bioconjchem.1c00137","article-title":"Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer Cells","volume":"32","author":"Pediconi","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41419-024-06653-2","article-title":"Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate","volume":"15","author":"Marrocco","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2024.102427_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20770","article-title":"Widespread in\u00a0vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers","volume":"9","author":"Fracasso","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.omtn.2024.102427_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2018.02.025","article-title":"The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in\u00a0vivo biodistribution and mitoxantrone encapsulation homogeneity","volume":"275","author":"Falvo","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2024.102427_bib42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/pharmaceutics12080774","article-title":"The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges","volume":"12","author":"He","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102427_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s40843-019-1231-y","article-title":"Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides","volume":"63","author":"L\u00f3pez-Laguna","year":"2020","journal-title":"Sci. China Mater."},{"key":"10.1016\/j.omtn.2024.102427_bib44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1021\/bc1000609","article-title":"Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape","volume":"21","author":"Chang","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib45","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1039\/c0an00184h","article-title":"Probing nucleobase mismatch variations by electrochemical techniques: exploring the effects of position and nature of the single-nucleotide mismatch","volume":"135","author":"Shamsi","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.omtn.2024.102427_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023443","article-title":"Designing of highly effective complementary and mismatch siRNAs for silencing a gene","volume":"6","author":"Ahmed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102427_bib47","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1093\/nar\/gkp835","article-title":"Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102427_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","article-title":"Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtn.2024.102427_bib49","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/ijms20071694","article-title":"Regulation of Proliferation, Differentiation and Functions of\u00a0Osteoblasts by Runx2","volume":"20","author":"Komori","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib50","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1074\/jbc.M805432200","article-title":"Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1\/2 and Protein Kinase C Signaling","volume":"284","author":"Miraoui","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/01.PRS.0000111593.96440.30","article-title":"Progressive postnatal craniosynostosis and increased intracranial pressure","volume":"113","author":"Connolly","year":"2004","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib52","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1097\/SCS.0000000000006931","article-title":"Progressive Postnatal Pansynostosis in Crouzon Syndrome","volume":"32","author":"Geisler","year":"2021","journal-title":"J.\u00a0Craniofac. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib53","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/SCS.0b013e31824e26d6","article-title":"Analysis of Morbidity and Mortality in Surgical Management of Craniosynostosis","volume":"23","author":"Lee","year":"2012","journal-title":"J.\u00a0Craniofac. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/pharmaceutics13040521","article-title":"Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization","volume":"13","author":"Yin","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102427_bib55","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.1073\/pnas.0609157103","article-title":"Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis","volume":"103","author":"Eswarakumar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102427_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1227\/01.neu.0000243302.07308.d2","article-title":"A model for the pharmacological treatment of crouzon syndrome","volume":"59","author":"Perlyn","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.omtn.2024.102427_bib57","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.3390\/cells11193129","article-title":"FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF\/FGFR-AMPK-Erk1\/2 Axis in Crouzon Syndrome","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102427_bib58","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI62644","article-title":"p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice","volume":"122","author":"Wang","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102427_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2017.08.016","article-title":"ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3","volume":"105","author":"Balek","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2024.102427_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1601-6343.2009.01460.x","article-title":"Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model","volume":"12","author":"Shen","year":"2009","journal-title":"Orthod. Craniofac. Res."},{"key":"10.1016\/j.omtn.2024.102427_bib61","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/jbmr.3204","article-title":"Inducible Activation of FGFR2 in Adult Mice Promotes Bone Formation After Bone Marrow Ablation","volume":"32","author":"Xu","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtn.2024.102427_bib62","article-title":"A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102427_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)63987-9","article-title":"In\u00a0vivo modulation of FGF biological activity alters cranial suture fate","volume":"158","author":"Greenwald","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2024.102427_bib64","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1074\/jbc.M512932200","article-title":"Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans","volume":"281","author":"McDowell","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib65","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PRS.0b013e3182412a50","article-title":"Parameters of care for craniosynostosis: craniofacial and neurologic surgery perspectives","volume":"129","author":"Warren","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.omtn.2024.102427_bib66","doi-asserted-by":"crossref","first-page":"45926","DOI":"10.1074\/jbc.M404824200","article-title":"A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome","volume":"279","author":"Tanimoto","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102427_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101693","article-title":"Therapeutic Effect of Nanogel-Based Delivery of Soluble FGFR2 with S252W Mutation on Craniosynostosis","volume":"9","author":"Yokota","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102427_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153795","article-title":"An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice","volume":"132","author":"Lees-Shepard","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102427_bib69","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1566523215666150812115730","article-title":"Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls","volume":"15","author":"Trochet","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102427_bib70","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ajmg.a.37640","article-title":"Apert and Crouzon syndromes-Cognitive development, brain abnormalities, and molecular aspects","volume":"170","author":"Fernandes","year":"2016","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1194-275","article-title":"Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2","volume":"8","author":"Jabs","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/ijri.IJRI_353_19","article-title":"Imaging diagnosis of Crouzon syndrome in two cases confirmed on genetic studies - with a brief review","volume":"29","author":"Grover","year":"2019","journal-title":"Indian J. Radiol. Imaging"},{"key":"10.1016\/j.omtn.2024.102427_bib73","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.95.8.4567","article-title":"Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain","volume":"95","author":"Robertson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102427_bib74","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000056833","article-title":"Clustering of FGFR2 gene mutations inpatients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses)","volume":"91","author":"Kress","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004390050668","article-title":"The mutations in FGFR2-associated craniosynostoses are clustered in five structural elements of immunoglobulin-like domain III of the receptor","volume":"102","author":"Steinberger","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","article-title":"Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy","volume":"23","author":"Kim","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102427_bib77","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by Dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102427_bib78","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/mtna.2012.6","article-title":"Deep Sequencing Analyses of DsiRNAs Reveal the Influence of 3\u2019 Terminal Overhangs on Dicing Polarity, Strand Selectivity, and RNA Editing of siRNAs","volume":"1","author":"Zhou","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102427_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nsmb780","article-title":"Kinetic analysis of the RNAi enzyme complex","volume":"11","author":"Haley","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102427_bib80","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA That Distinguish between Genes That Differ by a Single Nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2024.102427_bib81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2024.102427_bib82","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102427_bib83","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3390\/ijms24032979","article-title":"Emerging RUNX2-Mediated Gene Regulatory Mechanisms Consisting of Multi-Layered Regulatory Networks in Skeletal Development","volume":"24","author":"Hojo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib84","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.3390\/ijms23105776","article-title":"Whole Aspect of Runx2 Functions in Skeletal Development","volume":"23","author":"Komori","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/procel\/pwae008","article-title":"Skeletal stem cells in bone development, homeostasis and disease","volume":"15","author":"Yuan","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.omtn.2024.102427_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-018-0554-8","article-title":"Discovery of a periosteal stem cell mediating intramembranous bone formation","volume":"562","author":"Debnath","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102427_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52390-4","article-title":"Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In\u00a0vitro- In\u00a0vivo Assessment","volume":"9","author":"Raval","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102427_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174741","article-title":"Corrigendum to \u201csiRNA: Mechanism of action, challenges, and therapeutic approaches\u201d [Eur. J. Pharmacol. 905 (2021) 174178]","volume":"916","author":"Alshaer","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102427_bib89","first-page":"294","article-title":"Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.omtn.2024.102427_bib90","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-019-09098-w","article-title":"Cryo-EM structure of the human ferritin-transferrin receptor 1 complex","volume":"10","author":"Montemiglio","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102427_bib91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.08.010","article-title":"Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness","volume":"239","author":"Fracasso","year":"2016","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2024.102427_bib92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102427_bib93","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1039\/C6TB02862D","article-title":"Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery","volume":"5","author":"Meng","year":"2017","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.omtn.2024.102427_bib94","doi-asserted-by":"crossref","first-page":"e3415","DOI":"10.1002\/jgm.3415","article-title":"Histidine-enhanced gene delivery systems: The state of the art","volume":"24","author":"Hooshmand","year":"2022","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtn.2024.102427_bib95","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biomaterials.2016.05.006","article-title":"Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells","volume":"98","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2024.102427_bib96","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/nar\/gki193","article-title":"Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality","volume":"33","author":"Elm\u00e9n","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102427_bib97","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bone.2012.09.004","article-title":"Lim mineralization protein is involved in the premature calvarial ossification in sporadic craniosynostoses","volume":"52","author":"Lattanzi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2024.102427_bib98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bone.2019.02.004","article-title":"Corrigendum to \u201cBBS9 gene in nonsyndromic craniosynostosis: Role of the primary cilium in the aberrant ossification of the suture osteogenic niche\u201d [Bone 112 (July 2018) 58-70]","volume":"121","author":"Barba","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2024.102427_bib99","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/ijms19113336","article-title":"Graphene Oxide Induced Osteogenesis Quantification by In-Situ 2D-Fluorescence Spectroscopy","volume":"19","author":"Palmieri","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102427_bib100","doi-asserted-by":"crossref","first-page":"12278","DOI":"10.1039\/c3nr04268e","article-title":"Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin","volume":"5","author":"Falvo","year":"2013","journal-title":"Nanoscale"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:25:57Z","timestamp":1762601157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124003147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253124003147"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102427","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102427"}}